The gadolinium(III)-water hydrogen distance in MRI contrast agents.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Inorganic Chemistry

• Publication date

  2003-06-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/IC034414FPMID 12817950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.

  2002cited by this paper
• EPR spectroscopy of MRI-related Gd(III) complexes: simultaneous analysis of multiple frequency and temperature spectra, including static and transient crystal field effects.

  2001cited by this paper
• Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents.

  2000cited by this paper
• Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.

  1999cited by this paper
• A multinuclear MR study of Gd‐EOB‐DTPA: Comprehensive preclinical characterization of an organ specific MRI contrast agent

  1997cited by this paper
• Solvate structures in water‐methanol solutions of MRI contrast agents: Electron spin echo envelope modulation in gadolinium chelates

  1993cited by this paper

• Coordination clusters as emerging magnetic resonance imaging contrast agents

  2025cites this paper
• Water-soluble and -stable high-nuclearity gadolinium cluster via a ligand substitution strategy for enhanced effects in MRI

  2025cites this paper
• A biphasic nanoplatform with switchable biochemical programs for combined organelle-specific cancer therapy

  2025cites this paper
• Emerging Head and Neck Tumor Targeting Contrast Agents for the Purpose of CT, MRI, and Multimodal Diagnostic Imaging: A Molecular Review

  2024cites this paper
• Protein MRI Contrast Agents as an Effective Approach for Precision Molecular Imaging

  2024cites this paper
• Frequency swept pulses for the enhanced resolution of ENDOR spectra detecting on higher spin transitions of Gd(III).

  2023cites this paper
• Transparency in Biology: Making the Invisible Visible

  2021cites this paper
• Cyclodextrins: promising scaffolds for MRI contrast agents

  2021cites this paper
• Characterization of Americium and Curium Complexes with the Protein Lanmodulin: A Potential Macromolecular Mechanism for Actinide Mobility in the Environment.

  2021cites this paper
• Molecular Imaging-Guided Sonodynamic Therapy.

  2021cites this paper
• Multimodal Imaging with NIR Light

  2020cites this paper
• Gold nanomaterials functionalised with gadolinium chelates and their application in multimodal imaging and therapy.

  2020cites this paper
• Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect

  2020cites this paper
• Mechanism of Gd3+ uptake in gypsum (CaSO4·2H2O): Implications for EPR dating, REE recovery and REE behavior

  2019cites this paper
• Inner-sphere water and hydrogen bonds in lanthanide DOTAM complexes. A neutron diffraction study

  2018cites this paper
• Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

  2018cites this paper
• Probable ideal size of Ln3+-based upconversion nanoparticles for single and multimodal imaging

  2018cites this paper
• Small Gd(III) Tags for Gd(III)-Gd(III) Distance Measurements in Proteins by EPR Spectroscopy.

  2018cites this paper
• New insights into water‐soluble and water‐coordinated copper 15‐metallacrown‐5 gadolinium complexes designed for high‐field magnetic resonance imaging applications

  2018cites this paper
• Intramolecular Hydrogen Bonding Restricts Gd-Aqua-Ligand Dynamics.

  2017cites this paper
• High Relaxivity Gadolinium-Polydopamine Nanoparticles.

  2017cites this paper
• Computational engineering of small molecules to treat infectious diseases

  2017cites this paper
• Chiral cyclobutane scaffolds: their application in the the development of new functionalized organogelators, organocatalysts and MRI contrast agents /

  2017cites this paper
• Towards advanced paramagnetic nanoassemblies of highly ordered interior nanostructures as potential MRI contrast agents

  2017cites this paper
• Sequential growth of CaF2:Yb,Er@CaF2:Gd nanoparticles for efficient magnetic resonance angiography and tumor diagnosis.

  2017cites this paper
• Water-soluble tetraaqua Ln(III) glycinehydroximate 15-metallacrown-5 complexes towards potential MRI contrast agents for ultra-high magnetic field

  2016cites this paper
• The reliability of parameters obtained by fitting of (1)H NMRD profiles and (17)O NMR data of potential Gd(3+)-based MRI contrast agents.

  2016cites this paper
• Amphiphiles with polyethyleneoxide–polyethylenecarbonate chains for hydrophilic coating of iron oxide cores, loading by Gd(III) ions and tuning R2/R1 ratio

  2016cites this paper
• Gd(III) complexes as paramagnetic tags: Evaluation of the spin delocalization over the nuclei of the ligand.

  2016cites this paper
• A Hyaluronic Acid-Conjugated Gadolinium Hepatocyte-Specific T1 Contrast Agent for Liver Magnetic Resonance Imaging

  2015cites this paper
• MR imaging probes: design and applications.

  2015cites this paper
• Gd-DTPA-Dopamine-Bisphytanyl Amphiphile: Synthesis, Characterisation and Relaxation Parameters of the Nanoassemblies and Their Potential as MRI Contrast Agents.

  2015cites this paper
• The issues and tentative solutions for contrast-enhanced magnetic resonance imaging at ultra-high field strength.

  2014cites this paper
• A QUANTUM MECHANICAL STUDY OF STRUCTURAL AND ELECTRONIC DILUTION EFFECTS IN PARAMAGNETIC CHEMICAL EXCHANGE SATURATION TRANSFER AGENTS.

  2014cites this paper
• The confluence of structure and dynamics in lanthanide(III) chelates: how dynamics help define structure in solution.

  2014cites this paper
• Lanthanide(III) chelates as MRI contrast agents: A brief description

  2013cites this paper
• Gd2O3 nanoparticles: size-dependent nuclear magnetic resonance.

  2013cites this paper
• Lanthanide(III) complexes of some natural siderophores: a thermodynamic, kinetic and relaxometric study.

  2013cites this paper
• Coupling fast water exchange to slow molecular tumbling in Gd3+ chelates: why faster is not always better.

  2013cites this paper
• A new ditopic GdIII complex functionalized with an adamantyl moiety as a versatile building block for the preparation of supramolecular assemblies

  2013cites this paper
• Design of novel protein-based MRI contrast agernets with high relaxivity and stabilty for biomedical imaging

  2013cites this paper
• Structure, Dynamics, and Computational Studies of Lanthanide‐Based Contrast Agents

  2013cites this paper
• Relaxivity of gadolinium (III) complexes: theory and mechanism

  2013cites this paper
• Characterising gadofosveset for use in quantitative MRI studies

  2013cites this paper
• Direct measurement of the Mn(II) hydration state in metal complexes and metalloproteins through 17O NMR line widths.

  2013cites this paper
• From solvated ions to ion-pairing: a THz study of lanthanum(III) hydration.

  2013cites this paper
• Tailoring Encodable Lanthanide‐Binding Tags as MRI Contrast Agents

  2012cites this paper
• Magnetic Resonance Imaging Contrast Agents

  2012cites this paper
• Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.

  2012cites this paper
• Equilibrium and NMR relaxometric studies on the s-triazine-based heptadentate ligand PTDITA showing high selectivity for Gd3+ ions.

  2012cites this paper
• Nanomedicine: Emerging Field of Nanotechnology to Human Health

  2012cites this paper
• Novel Polysaccharide Based Polymers and Nanoparticles for Controlled Drug Delivery and Biomedical Imaging

  2012cites this paper
• ' s personal copy The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-speci fi c T 1 contrast agent for MRI

  2011cites this paper
• The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI.

  2011cites this paper
• Outer-sphere investigation of MRI relaxation contrast agents. Example of a cyclodecapeptide gadolinium complex with second-sphere water.

  2010cites this paper
• High Relaxivity Magnetic Resonance Imaging Contrast Agents Part 1: Impact of Single Donor Atom Substitution on Relaxivity of Serum Albumin-Bound Gadolinium Complexes

  2010cites this paper
• Computational Estimation of Lanthanoid-Water Bond Lengths by Semiempirical Methods

  2010cites this paper
• Sparkle/PM6 Parameters for all Lanthanide Trications from La(III) to Lu(III).

  2010cites this paper
• PAMAM dendrimers conjugated with an uncharged gadolinium(III) chelate with a fast water exchange: the influence of chelate charge on rotational dynamics.

  2009cites this paper
• A gadolinium-binding cyclodecapeptide with a large high-field relaxivity involving second-sphere water.

  2009cites this paper
• Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.

  2009cites this paper
• Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents.

  2009cites this paper
• Investigations into building block structure and method of preparation on the properties of nanomaterials

  2009cites this paper
• High-Frequency EPR and ENDOR Characterization of MRI Contrast Agents

  2009cites this paper
• Pyridine-N-oxide analogues of DOTA and their gadolinium(III) complexes endowed with a fast water exchange on the square-antiprismatic isomer.

  2009cites this paper
• A rigorous framework to interpret water relaxivity. The case study of a Gd(III) complex with an alpha-cyclodextrin derivative.

  2008cites this paper
• High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents.

  2008cites this paper
• Small molecular gadolinium(III) complexes as MRI contrast agents for diagnostic imaging

  2007cites this paper
• Structural, kinetic, and thermodynamic characterization of the interconverting isomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent.

  2007cites this paper
• Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent.

  2007cites this paper
• Structure, stability, dynamics, high-field relaxivity and ternary-complex formation of a new tris(aquo) gadolinium complex.

  2007cites this paper
• Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.

  2006cites this paper
• Determination of the hydration number of gadolinium(III) complexes by high-field pulsed 17O ENDOR spectroscopy.

  2006cites this paper
• Gd(III)-BASED CONTRAST AGENTS FOR MRI

  2005cites this paper
• Quantum chemical investigation of hyperfine coupling constants on first coordination sphere water molecule of gadolinium(III) aqua complexes.

  2005cites this paper
• Probing the water coordination of protein-targeted MRI contrast agents by pulsed ENDOR spectroscopy.

  2005cites this paper
• Synthesis of a bifunctional monophosphinic acid DOTA analogue ligand and its lanthanide(III) complexes. A gadolinium(III) complex endowed with an optimal water exchange rate for MRI applications.

  2005cites this paper
• Lanthanide(III) complexes of a mono(methylphosphonate) analogue of H4dota: the influence of protonation of the phosphonate moiety on the TSAP/SAP isomer ratio and the water exchange rate.

  2005cites this paper
• When are two waters worse than one? Doubling the hydration number of a Gd-DTPA derivative decreases relaxivity.

  2005cites this paper
• Multilocus binding increases the relaxivity of protein-bound MRI contrast agents.

  2005cites this paper
• Hetero-tripodal hydroxypyridonate gadolinium complexes: syntheses, relaxometric properties, water exchange dynamics, and human serum albumin binding.

  2004cites this paper
• Metal Complexes as MRI Contrast Enhancement Agents

  2004cites this paper
• Lanthanide chelates containing pyridine units with potential application as contrast agents in magnetic resonance imaging.

  2004cites this paper
• Synthesis and physicochemical characterization of Gd-DTPA-B(sLex)A, a new MRI contrast agent targeted to inflammation.

  2004cites this paper
• Scandium, yttrium, the lanthanides and the actinides

  2002cites this paper